chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reports that she went to read a magazine and then realized she couldn't see anything out of her right eyes. She states she remembered she has mono vision so she covered her left eye and was unable to see out of the right eye at all. She states that everything was black.
Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Thyroid disorder NOS and Hypercholesteremia. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], NITROGLYCERIN, MAGNESIUM and VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]) for an unknown indication.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Blood glucose increased: 191 (High) Usually 125-133  every morning..         Action taken with mRNA-1273 in response to the events was not applicable. No treatment medication details was reported.
Extremely tired; Mild fever; Unable to lift arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 12:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included heart disorder. The patient had no Allergies to medications, food, or other products. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 12:30, the patient experienced unable to lift arm, extremely tired and mild fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events unable to lift arm, extremely tired and mild fever was resolving at the time of the report.  No follow-up attempts are needed; information about the lot number cannot be obtained.  No further information is expected
Severe chills, back and neck ache, fever,- onset 10:00PM to 4:30AM, residual fever reduced after Tylenol taken at 6:00AM; localized soreness left arm- onset 1:00PM, reduced but still present today, 2/25 at 10:48AM
Started feeling fatigued and congested , took a home COVID-19 test and was Positive. Called PCP and was prescribed Paxlovid. A few days later was given the antibiotic Arthromycin and it helped. Then about 2 weeks later experienced Paxlovid rebound, didn't see his Dr. Has fully recovered.
Patient was at his residence. self reported sore arm muscle from injection. was in hot tub, unknown amount of time. got out to check his temperature and fell and hit head on floor. unknown amount of time unresponsive. witnessed seizure activity/ severe muscle cramping post fall en route to ED and also in ED. Possible diagnosis: new onset seizures, rule out rhabdomylosis
Left lymph node has been swollen since the vaccination; This is a spontaneous report from a contactable consumer, the parent. An adult non-pregnant female patient of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 25Feb2021 at 08:15 as a single dose for COVID-19 immunisation. Medical history included asthma and rheumatoid arthritis from an unknown date and unknown if ongoing. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included salbutamol (VENTOLIN) for asthma and budesonide, formoterol fumarate (SYMBICORT) for an unknown indication; both from an unknown date and unknown if ongoing. On 25Feb2021 (also reported as on 27Feb2021 at 13:00), the patient experienced left lymph node which was swollen since the vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event left lymph node which was swollen since the vaccination which included treatment with unspecified medicine lozenges (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing. Since the vaccination, the patient had been tested for COVID-19. On 28Feb2021, the patient underwent nasal swab test SARS CoV-2 test and the result was negative. The clinical outcome of the event left lymph node has been swollen since the vaccination was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
administered incorrectly/ little to far into like the shoulder area; can't move her arm; lot of pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (administered incorrectly/ little to far into like the shoulder area), HYPOKINESIA (can't move her arm) and PAIN (lot of pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 14-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (administered incorrectly/ little to far into like the shoulder area), HYPOKINESIA (can't move her arm) and PAIN (lot of pain). On 14-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (administered incorrectly/ little to far into like the shoulder area) had resolved. At the time of the report, HYPOKINESIA (can't move her arm) and PAIN (lot of pain) had not resolved. Not Provided           Concomitant products included were blood pressure medication. No treatment medications were reported.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with AEs of hypokinesia and pain
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-079218 (Patient Link).
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a 36 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: human immunodeficiency virus. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: UNKNOWN) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-AUG-2021, the patient experienced covid-19 test positive. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Fatigue, muscle and joint pain chills, temperature going on 6 days. I went back to cwork today appears to be reaction.
Call this afternoon regarding safety of in setting of recent Moderna COVID-19 vaccine receipt.     Question related to autoimmune heparin-like thrombotic thrombocytopenia as currently in the news related to J&J vaccine.  Reported incidents that led to FDA pause of J&J vaccine related to arterial events with overt thrombocytopenia and PF4 antibody positive. Limited data available to suggest link to mRNA vaccines at this time but data being collected daily regarding therapies.     Reviewing chart, patient has several risk factors for VTE development (OSA, hx prostate cancer, age, PMR +/- steroids; there is also a mention of unilateral edema in which patient was referred for Doppler but date of this request is unknown to writer so unable to determine if occurred prior to or after vaccine receipt. Also mention of knee pain back to 3/2021 OV with Dr. so unclear if mobility issues although participants in cardiac rehab.     Labs reviewed and mild thrombocytopenia today (148k) and 171k on 10/2020.     Naranjo score 2, suggesting possible correlation but low score overall.     Overall, given presentation and information provided, appears anticoagulation for acute PE is safe. Theoretically would consider enoxaparin 80 mg SQ BID over UFH infusion but defer to medicine.   Additional notes:  2D echo: EF wnl, impaired LV diastolic filling  bilat LE dopplers; negative for DVT  He was transitioned to eliquis RX for PE treatment Discussed AC treatment with on call cardiology, as no stents are in place that I am aware of and the patient denies placement of stents, only CABG in 1995, then stop asa/plavix and continue only with eliquis at this time  Recommend f/u with hematology/oncology in the next 2 weeks for PE management and evaluation  Recommend f/u with Cardiology in the next 2 weeks for further management  AC precautions was reviewed with the patient and his wife prior to discharge and including when to seen medical attention due to increased risk of bleeding events. They both verbalized understanding.
Generalize urticaria, very itchy,  pruritic rash on and off which she disappears within 24 hours with Benadryl and then comes back in a different part of the body.  especially itchy hands and feet. Some raised macropules No change of diet, no new food, no new detergent, no pets, no traveling,etc.  No difficulty breathing, wheezing, swelling of the throat or mouth.  Prominent dermatographism. 1 Benadryl and 1 Zyrtec helped a bit but not completely. Allegra 24 hrs 1  in the morning and 1 hydroxyzine 10 mg at night seemed to work better. Cortzione creams don't help. Creams with dimethicone help with itchiness After 3 weeks, it seemed to decrease in intensity, and the itchy rash in any place disappears within the hour.  but reappears within hours somewhere else.
Most of upper outer left arm red, sore, slightly swollen.  Rx Tylenol.
Hives ten minutes after FLUZONE HD. Treated with BENADRYL 75 mg IM.
pt recvd 1st dose of Hep B vax 11DEC90 & exp. nausea,itchy eyes,warmth,flushing & hives on neck & face w/ BP of 122/70.
Pain in face; teeth hurt a lot; severe pain under her armpits; mild fever; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever). At the time of the report, FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.
Information has been received from a physician concerning a 2-month-old patient with a mild milk soy protein intolerance (MSPI) who was vaccinated PO with a 2.0 mL dose of Rotateq. The physician reported that for a 10 day period after being vaccinated, the patient developed anorexia characterized by a 6 oz. weight loss as they were not eating. The physician also reported that the patient was also kind of "spitty." Unspecified medical attention was sought. The patient subsequently recovered. Additional information has been requested.
patient was pricked before the needle prematurely retracted. New needle with full dose administerred
did get a terrible case of the flu; did get a terrible case of the flu; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not applicable for this report. It was reported that several people that get the flu shot regularly and they get the flu every year. The people purposely knowing that they would more than likely get the flu right after getting the flu shot every year, year after year. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test was unknown. This is 1 of 4 cases reported by same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR157706:same reporter US-GLAXOSMITHKLINE-US2020AMR165254:same reporter US-GLAXOSMITHKLINE-US2020AMR165248:same reporter
Patient developed shortness of breath and "barky cough" 5 days after first COVID 19 vaccination.  Chest imaging revealed pulmonary embolism.  Patient was hospitalized for 4 days and discharged on anticoagulation.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown date in 2012, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On an unknown date in 2014, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Dizziness, Headache, Myalgia, Arthralgia, Diarrhea, chills, nasal congestion, loss of appetite, vaginal spotting Narrative:  The evening she received the second dose of the Moderna COVID-19 vaccine, the patient reported a stuffy nose. The following day, she experienced a headache, body aches, chills, diarrhea, loss of appetite, and vaginal spotting. She took acetaminophen 500mg every four hours for her symptoms.
Redness, warmth, induration, left thigh, 10 cm x 8 cm. Treated with cephalexin for suspected cellulitis.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 09-APR-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016) (dose and route not reported). The temperature and time of excursion was 0.55 C for 560 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Constant Itchy skin on face, neck, chest, arms and stomach with no rash lasting  8 months.
Pt developed severe pain around injection area (left deltoid) and anterior chest had red spots at vaccination site and chest. Given injection of Kenalog and Benadryl. While waiting for treatment pt became nauseous. Lungs were clear.
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Additional Details: pt states had usual arm soreness at the vaccination site, but she notes that on wednesday, the 19th of october, was more sore, and started itching and throbbing and was red.  Pt had attempted to apply cold compresses.  advised to apply cold compresses and to take appropriate analgesic and to follow up with pcp.  pt stated she was already on an anithistamine.  she reports no issues moving arm around, no shoulder pain
I had a pain in my left eye. Seemed like a nerve of some sort.; I had a pain in my left eye. Seemed like a nerve of some sort.; Seemed like a nerve of some sort. That led to my left eye not wanting to open; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 (Lot number: EW0182) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: EYE PAIN (non-serious), NEURALGIA (non-serious) all with onset May2021, outcome "recovered" (May2021) and all described as "I had a pain in my left eye. Seemed like a nerve of some sort."; OCULAR DISCOMFORT (non-serious) with onset May2021, outcome "recovered" (May2021), described as "Seemed like a nerve of some sort. That led to my left eye not wanting to open". Therapeutic measures were not taken as a result of eye pain, neuralgia, ocular discomfort. Additional information: the patient was not pregnant at vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within in two weeks of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Patient had not been tested since the vaccination. The Patient did not have known allergies. Facility where the most recent COVID-19 vaccine was administered was available. After receiving the first dose, the patient had a pain in her left eye. Seemed like a nerve of some sort. That led to her left eye not wanting to open, and then being forced to open. This eventually wore off. The adverse events did not result in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care or Hospitalization.  No follow-up attempts are possible. No further information is expected.
Patient was given a the booster pfizer shot a week early. Vaccinator misread the date by confusing the first shot date with the second date.
Tachycardia one day after second vaccination, along with the normal side effects of body aches, fever, chills, ache at vaccination site, nausea, fatigue.  After the first vaccination, infected kidney from a prior UTI that took place two weeks prior to the first vaccine.
Moderate fatigue - unresolved mild headache - unresolved diarrhea - resolved 2/19/2021 joint pain - resolved 2/22/21 increased blood pressure - resolved 2/19/2021 swollen eye lids and upper checks - resolved 2/22/2021
Patient states that within 24 hours of vaccination, her arm developed a red mark, the size of a softball, around the vaccination site. The site of immunization had a slightly darker color than the rest of the red mark. When she came to pharmacy, the mark had gotten smaller. She states the area was warm to the touch but did not cause any discomfort or pain.
Rash on chest and cheeks. Temp 101-102 degrees over the weekend after injection 22-23MAY2004.
pt recv vax 6MAY96 & 10JUN97 pt devel a varicella zoster type rash 2wk p/son had varicella zoster;rash consisted of approx 50 pruritic lesions on scalp, face, chest, back & abd;also edema;
Follow-up information received from pt's physician provided the following: adverse event information including symptoms, onset and recovery status; pt's gender and date of birth; concomitant medications (none); concomitant vaccines (none); illnesses at time of vaccination (none); and medical history (negative).  A health care professional reported that a 44 year old female pt received a dose of Flumist (2003-2004 formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) on an unspecified date in 10/03 and experienced flu-like symptoms, sore throat, nasal congestion, muscle aches, low-grade fever and chills.  The pt had no relevant medical history.  Indication for Flumist (2003-2004 formula) was immunization.  Product was administered on an unspecified date in 10/03.  Dose regimen was 1 dose 1 time per day (IN).  The pt was not taking any concomitant medications.  Within 24 hours of vaccination, the pt experienced flu-like symptoms, sore throat, nasal congestion, muscle aches, low-grade fever, and chills.  The symptoms lasted for three days. The pt has recovered.  See related case(s): HQWYE626029OCT03 (adverse event, non-expedited).